Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Novel 4-month Pan-TB Regimen Targeting Both Host and Microbe (panTB-HM)

NCT05686356 is registered in ClinicalTrials.gov with The Aurum Institute NPC as lead sponsor.

NCT NCT05686356
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05686356 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Novel 4-month Pan-TB Regimen Targeting Both Host and Microbe (panTB-HM)
Lead sponsor
The Aurum Institute NPC
Phase
Phase 2/3
Overall status
Active, not recruiting
Start date
July 28, 2023
Completion date
January 31, 2026
Enrollment
352 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

tuberculosis